Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2025-04-21 Annual Report
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Báo cáo thường niên năm 2024
Annual Report Classification · 95% confidence The document is titled “BÁO CÁO THƯỜNG NIÊN NĂM 2024” (Annual Report 2024), contains extensive sections such as business overview, audited financial statements, governance structure, management discussions, mission/vision, distribution network, and full audited accounts. It is a comprehensive yearly report rather than an announcement, transcript, or presentation. Therefore, it matches the definition of an Annual Report (10-K). FY 2024
2025-04-21 Vietnamese
DBT: Nghị quyết HĐQT về việc nhận cấp tín dụng tại MB Bank
Capital/Financing Update Classification · 85% confidence The document is a Vietnamese ‘Công bố thông tin bất thường’ filed with the State Securities Commission and stock exchange. It announces a Board of Directors resolution to obtain a VND 120 billion credit facility and related collateral at a commercial bank. There are no financial statements or performance metrics—as this is purely a debt financing update. Under our taxonomy, this falls under “Capital/Financing Update” (CAP).
2025-04-15 Vietnamese
DBT: Nghị quyết HĐQT về việc tham dự các cuộc họp ĐHĐCĐ tại các công ty do DBT góp vốn
Regulatory Filings Classification · 82% confidence The document is a Vietnamese-language “thông tin bất thường” filing to the State Securities Commission and Ho Chi Minh Stock Exchange. It is an announcement of a Board of Directors resolution authorizing the company’s CEO as a representative to attend shareholders’ meetings of investee companies. It is not an earnings release, financial report, dividend notice, or appointment/removal of directors. It does not present substantive financial statements. Instead, it is a miscellaneous regulatory filing disclosing a Board resolution. This falls under the catch-all “Regulatory Filings” category (RNS).
2025-04-09 Vietnamese
DBT: Nghị quyết HĐQT về việc thông qua chương trình ĐHĐCĐ
Regulatory Filings Classification · 45% confidence The document is a Board of Directors’ resolution concerning the organization of the upcoming Annual General Meeting (AGM) for fiscal year 2024. It sets the time, venue, and agenda for the AGM and provides a link to meeting materials. It is not the AGM materials themselves (AGM-R), nor is it a proxy solicitation statement (PSI) with detailed voting forms, nor a report release. As it does not fit any specific category, it defaults to a general regulatory announcement. Therefore, it is classified as Regulatory Filings (RNS).
2025-04-04 Vietnamese
DBT: Thông báo họp và tài liệu họp ĐHĐCĐ thường niên năm 2025
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a detailed notice of the annual general meeting (Đại hội đồng Cổ đông thường niên năm tài chính 2024), including the meeting invitation, agenda, list of resolutions, proxy form and registration instructions sent to shareholders to solicit attendance and votes. It is not the actual annual report, financial statements, or post-meeting results, but rather the proxy solicitation/information statement for the AGM. Thus it best fits the Proxy Solicitation & Information Statement category (PSI).
2025-04-04 Vietnamese
DBT: Nghị quyết HĐQT số 17 ngày 27/03/2025
Regulatory Filings Classification · 75% confidence The document is an extraordinary disclosure (“Công bố thông tin bất thường”) by a listed company advising the State Securities Commission and Ho Chi Minh Stock Exchange of a Board resolution to contribute additional capital to another company. It is not an earnings release, management change, AGM material, or formal financial report, nor a proxy or dividend notice. It does not itself raise funds but simply announces the related Board decision as a regulatory filing under Vietnamese securities rules. Therefore it falls into the general “Regulatory Filings” category.
2025-03-28 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.